Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study

Objectives To investigate the influence of gender on disease outcomes in patients with spondyloarthritis (SpA), including across SpA subtypes.Methods Data from 4185 patients of 23 countries with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or psoriatic arthritis (PsA) from the Assessment...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofia Ramiro, Maxime Dougados, Anna Molto, Clementina López-Medina, Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik
Format: Article
Language:English
Published: BMJ Publishing Group 2022-09-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002514.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823868558594015232
author Sofia Ramiro
Maxime Dougados
Anna Molto
Clementina López-Medina
Victoria Navarro-Compán
Diego Benavent
Dafne Capelusnik
author_facet Sofia Ramiro
Maxime Dougados
Anna Molto
Clementina López-Medina
Victoria Navarro-Compán
Diego Benavent
Dafne Capelusnik
author_sort Sofia Ramiro
collection DOAJ
description Objectives To investigate the influence of gender on disease outcomes in patients with spondyloarthritis (SpA), including across SpA subtypes.Methods Data from 4185 patients of 23 countries with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or psoriatic arthritis (PsA) from the Assessment of SpondyloArthritis International Society (ASAS)-perSpA study were analysed. Associations between gender and disease activity (Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Score (BASDAI), C-reactive protein (CRP)), function (Bath Ankylosing Spondylitis Functional Index (BASFI)) and overall health (ASAS Health Index (ASAS HI), European Quality of Life Five Dimension (EQ-5D)) outcomes were investigated. Multilevel multivariable linear mixed models adjusted for relevant confounders (and stratified by disease subtype in case of a relevant interaction) were used.Results In total, 65%, 10% and 25% of patients had axSpA, pSpA and PsA, respectively. axSpA was more frequent in males (68%), whereas pSpA and PsA were more frequent in females (53% and 52%, respectively). A significant interaction between gender and disease subtype was found for ASDAS, BASDAI and BASFI. While being female independently contributed to higher BASDAI across the three disease subtypes (with varying magnitude), female gender was only associated with higher ASDAS in pSpA (β (95% CI): 0.36 (0.15 to 0.58)) and PsA (0.25 (0.12 to 0.38)) but not in axSpA (0.016 (−0.07 to 0.11)). No associations were observed between gender and CRP levels. Female gender was associated with higher ASAS HI and EQ-5D, without differences across disease subtype.Conclusion Female gender is associated with less favourable outcome measures across the SpA spectrum. However, while female gender influences BASDAI across the three subtypes, ASDAS is associated with gender only in pSpA and PsA but not in axSpA. Therefore, ASDAS is an appropriate instrument both for females and males with axSpA.
format Article
id doaj-art-53ff73defa6a49a7816adbbaa6118e70
institution Kabale University
issn 2056-5933
language English
publishDate 2022-09-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-53ff73defa6a49a7816adbbaa6118e702025-02-08T05:50:11ZengBMJ Publishing GroupRMD Open2056-59332022-09-018210.1136/rmdopen-2022-002514Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA studySofia Ramiro0Maxime Dougados1Anna Molto2Clementina López-Medina3Victoria Navarro-Compán4Diego Benavent5Dafne Capelusnik6Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, NetherlandsRheumatology, Hospital Cochin, Université Paris Descartes Faculté de Médecine, Paris, France21 Rheumatology, Hopital Cochin, paris, Ile de France, FranceMaimonides Biomedical Research Institute of Cordoba, University of Cordoba, Cordoba, SpainRheumatology, Hospital Universitario La Paz, Madrid, SpainRheumatology, Hospital Universitario La Paz, Madrid, SpainUniversiteit Maastricht Care and Public Health Research Institute, Maastricht, The NetherlandsObjectives To investigate the influence of gender on disease outcomes in patients with spondyloarthritis (SpA), including across SpA subtypes.Methods Data from 4185 patients of 23 countries with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or psoriatic arthritis (PsA) from the Assessment of SpondyloArthritis International Society (ASAS)-perSpA study were analysed. Associations between gender and disease activity (Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Score (BASDAI), C-reactive protein (CRP)), function (Bath Ankylosing Spondylitis Functional Index (BASFI)) and overall health (ASAS Health Index (ASAS HI), European Quality of Life Five Dimension (EQ-5D)) outcomes were investigated. Multilevel multivariable linear mixed models adjusted for relevant confounders (and stratified by disease subtype in case of a relevant interaction) were used.Results In total, 65%, 10% and 25% of patients had axSpA, pSpA and PsA, respectively. axSpA was more frequent in males (68%), whereas pSpA and PsA were more frequent in females (53% and 52%, respectively). A significant interaction between gender and disease subtype was found for ASDAS, BASDAI and BASFI. While being female independently contributed to higher BASDAI across the three disease subtypes (with varying magnitude), female gender was only associated with higher ASDAS in pSpA (β (95% CI): 0.36 (0.15 to 0.58)) and PsA (0.25 (0.12 to 0.38)) but not in axSpA (0.016 (−0.07 to 0.11)). No associations were observed between gender and CRP levels. Female gender was associated with higher ASAS HI and EQ-5D, without differences across disease subtype.Conclusion Female gender is associated with less favourable outcome measures across the SpA spectrum. However, while female gender influences BASDAI across the three subtypes, ASDAS is associated with gender only in pSpA and PsA but not in axSpA. Therefore, ASDAS is an appropriate instrument both for females and males with axSpA.https://rmdopen.bmj.com/content/8/2/e002514.full
spellingShingle Sofia Ramiro
Maxime Dougados
Anna Molto
Clementina López-Medina
Victoria Navarro-Compán
Diego Benavent
Dafne Capelusnik
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
RMD Open
title Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
title_full Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
title_fullStr Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
title_full_unstemmed Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
title_short Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study
title_sort does gender influence outcome measures similarly in patients with spondyloarthritis results from the asas perspa study
url https://rmdopen.bmj.com/content/8/2/e002514.full
work_keys_str_mv AT sofiaramiro doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT maximedougados doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT annamolto doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT clementinalopezmedina doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT victorianavarrocompan doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT diegobenavent doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy
AT dafnecapelusnik doesgenderinfluenceoutcomemeasuressimilarlyinpatientswithspondyloarthritisresultsfromtheasasperspastudy